Dr. Patience Atuhaire has over 11 years’ experience in HIV related research at Makerere University Johns Hopkins University (MU-JHU) Research collaboration, Kampala, Uganda. She holds a medical degree (MBChB) from Mbarara University of Science and Technology (2008) and a Master of Public Health at Makerere University School of Public health (2019). She completed the Harvard medical School Global Clinical Scholars Research training program with a commendation in the capstone project (GCSRT-2014).

She is a co-Investigator of the Moderna Vaccine trial (COVPN 3008) and a study coordinator of the Metabolic Impact of Dolutegravir to Postpartum women living with HIV and their infants at the MUJHU site. She was the lead principal investigator of PROMOting Adherence to ART (PROMOTA) study a sub study of the US PEPFAR funded multi-site PROMOTE (PROMise Ongoing Treatment Evaluation longitudinal study at MUJHU. She has participated in the oversight of implementation activities of the NIH funded Promoting Maternal and Infant Survival Everywhere (PROMISE) a phase III Prevention of  Mother to Child transmission of HIV trial, the Maternal Repeat Pregnancy Bone Health Study assessing the Bone Mineral Density changes among women living with HIV having multiple pregnancies and breastfeeding; Neurodevelopmental (ND) study whose participants’ were co-enrolled from the PROMISE trial and the SOAR funded small research utilization grant to promote HIV disclosure in children (Dialogue Intervention to Support Communication and Openness (DISCO kids) as a study coordinator. She has authored research articles as primary author and many others as co-author in peer reviewed journals.

Dr. Atuhaire has a passion for leadership and serves as the President of the Association of Uganda Women Medical Doctors (2023-2025) among other community-based positions.